Skip to main content
. 2021 Apr 19;23(11):2394–2401. doi: 10.1007/s12094-021-02620-x

Fig. 1.

Fig. 1

Changes in the expression of regulatory T cells, PD-1+ T cells and TIM-3+ T cells divided in CD4+ and CD8+ subgroups. Patients marked with * received gemcitabine/nab-paclitaxel, all others FOLFIRINOX